News archive

2010

Last patient out for Paccal® Vet Phase III study

2010-03-01

Interim report May 1, 2009 - January 31, 2010

2010-02-26

Oasmia changes report publication date

2009-12-28

2009

Oasmia publishes Interim Report for May - Oct

2009-12-10

Oasmia starts clinical studies with Doxophos® Vet

2009-12-09

Oasmia carries out private placement

2009-11-05

Oasmia successfully concludes enrolment

2009-10-21

Communiqué from Annual General Meeting

2009-09-28

Interim report May 1 - July 31 2009

2009-09-10

Oasmia’s rights issue fully subscribed

2009-08-28

Notice of Annual General Meeting 2009

2009-08-27

Oasmia SA’s commitment in rights issue

2009-08-25

Oasmia announces distribution agreement

2009-07-13

Oasmia publishes prospectus

2009-08-03

Oasmia announces license agreement with Abbott

2009-07-10

Oasmia proposes new share issue

2009-06-24

Prize to Oasmia

The 29th of April Oasmia received a award in Stockholm

FDA grants Paclical® Orphan Drug Designation

2009-04-14

Oasmia: FDA grants Paccal Vet Minor Use status

2009-04-01

Interim Report May 2008 - January 2009

2009-03-19

Phase III study generates great interest in Europe

2009-02-11

Oasmia aims for global registration of Paccal Vet

2009-02-05

Communiqué from Extraordinary General Meeting

2009-02-02

Promising clinical results for Paclical

2009-01-27

Solid scientific evidence for Paccal Vet

2009-01-21

FDA grants Expedited Review Status to Paclical Vet

2009-01-14

Call to Extraordinary Genral Meeting

2009-01-12

2008

Oasmia appoints market maker

2008-12-01

Oasmia changes marketplace

2008-10-01

Notice of Annual General Meeting

2008-08-14

Oasmia expands license agreement for Paclical Vet

2008-06-25

New license agreement with Orion Corporation

2008-03-26

Phase III results presented in Copenhagen

2008-03-03

Oasmia presents Phase III-results in Denmark

2008-01-31

Final advice for Paclical Phase III program

2008-01-29

Older

Oasmia announces licensing agreement

2007-11-27

Oasmia presented in Florida

2007-11-05

Oasmia presents in USA

2007-10-09

Oasmia in Barcelona

2007-09-27

Great interest for Oasmia in Budapest

2007-09-20

Oasmia to NGM Equity

2007-09-17

Oasmia publishes Listing Prospectus

2007-09-17

Oasmia presents in Budapest

2007-06-19

“Jackpot in sight for Oasmia”

2007-06-07

Status – listing of Oasmia

2007-05-29

Very good clinical results for Paclical®

2007-04-16

Unique results for cancer drug

2007-03-27

New drug for treatment of cancer in dog

2007-03-13

OASMIA confirms Orphan Drug Designation

2006-11-30

Oasmia obtains Orphan Drug designation

2006-11-15